Heart valve diseases, particularly rheumatic heart disease and degenerative aortic stenosis remain a major burden in India. It is worsened by socioeconomic challenges and limited healthcare access. Against this backdrop, India’s transcatheter aortic valve replacement (TAVR) market is forecast to register a compound annual growth rate (CAGR) of around 24 per cent between 2024 and 2033, according to GlobalData.
GlobalData’s latest report, ‘Transcatheter Aortic Valve Replacement (TAVR) Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036’, reveals that India accounted for only around 3 per cent of the transcatheter aortic heart valve replacement market in the Asia-Pacific (APAC) in 2024, due to the restricted availability and high cost of TAVR procedures, coupled with competition from established players.
Abbott Laboratories has recently introduced Navitor Vision, its latest transcatheter aortic valve implantation (TAVI) system, in India. Representing the latest advancement in Abbott’s Navitor TAVI/TAVR technology, this device offers an efficient treatment option for patients with critical aortic stenosis and who have a high likelihood of complications from open-heart surgery.
Shreya Jain, Medical Devices Analyst, GlobalData, comments: “With TAVI/TAVR emerging as a less invasive alternative to traditional open-heart surgery to treat heart valve diseases, these procedures need refinement in several key areas. Challenges remain in achieving consistent and accurate valve placement, especially in patients with complex anatomy, which can lead to paravalvular leaks. Precise valve sizing is also crucial to expand the applicability of TAVR/TAVI to a wider range of patients.”
The Navitor platform has been improved with three large vision markers for enhanced visibility and easier valve placement during a TAVI/TAVR procedure. It also comes in different sizes to fit a variety of heart openings and a dynamic sealing cuff that reduces blood leakage back to the heart.
Jain concludes, “Increased affordability and accessibility, coupled with growing awareness and ongoing research, will be key to the expansion of the TAVR market in India. Improved valve design, advanced imaging, and refined transcatheter delivery systems will further be crucial for better patient outcomes.”
Edits made by EH News Bureau